Ege David S. has filed 20 insider transactions across 1 company since February 2023.
Most recent transaction: a option exercise of 2969 shares of Seres Therapeutics, Inc. ($MCRB) on August 15, 2024.
Activity breakdown: 0 open-market purchases and 5 sales.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Aug. 15, 2024 | Seres Therapeutics, Inc. | $MCRB | Ege David S. | See Remarks | M | Common Stock | 2969 | $0.00 | 78,703.0000 | 0 | 3.92% | 0.00% |
| Aug. 16, 2024 | Seres Therapeutics, Inc. | $MCRB | Ege David S. | See Remarks | S | Common Stock | 1128 | $0.84 | 77,575.0000 | 0 | 1.43% | 0.00% |
| Aug. 15, 2024 | Seres Therapeutics, Inc. | $MCRB | Ege David S. | See Remarks | M | Restricted Stock Units | 2969 | $0.00 | 29,688.0000 | 0 | 9.09% | 0.00% |
| May 15, 2024 | Seres Therapeutics, Inc. | $MCRB | Ege David S. | See Remarks | M | Common Stock | 2968 | $0.00 | 76,824.0000 | 0 | 4.02% | 0.00% |
| May 15, 2024 | Seres Therapeutics, Inc. | $MCRB | Ege David S. | See Remarks | S | Common Stock | 1090 | $0.94 | 75,734.0000 | 0 | 1.42% | 0.00% |
| May 15, 2024 | Seres Therapeutics, Inc. | $MCRB | Ege David S. | See Remarks | M | Restricted Stock Units | 2968 | $0.00 | 32,657.0000 | 0 | 8.33% | 0.00% |
| Feb. 15, 2024 | Seres Therapeutics, Inc. | $MCRB | Ege David S. | See Remarks | M | Common Stock | 11875 | $0.00 | 78,866.0000 | 0 | 17.73% | 0.00% |
| Feb. 16, 2024 | Seres Therapeutics, Inc. | $MCRB | Ege David S. | See Remarks | S | Common Stock | 5010 | $1.08 | 73,856.0000 | 0 | 6.35% | 0.00% |
| Feb. 14, 2024 | Seres Therapeutics, Inc. | $MCRB | Ege David S. | See Remarks | A | Stock Option (Right to Buy) | 187500 | $0.00 | 187,500.0000 | 0 | 9999.99% | 0.00% |
| Feb. 14, 2024 | Seres Therapeutics, Inc. | $MCRB | Ege David S. | See Remarks | A | Stock Option (Right to Buy) | 287905 | $0.00 | 287,905.0000 | 0 | 9999.99% | 0.00% |
| Feb. 14, 2024 | Seres Therapeutics, Inc. | $MCRB | Ege David S. | See Remarks | A | Restricted Stock Units | 31250 | $0.00 | 31,250.0000 | 0 | 9999.99% | 0.00% |
| Feb. 15, 2024 | Seres Therapeutics, Inc. | $MCRB | Ege David S. | See Remarks | M | Restricted Stock Units | 11875 | $0.00 | 35,625.0000 | 0 | 25.00% | 0.00% |
| Oct. 27, 2023 | Seres Therapeutics, Inc. | $MCRB | Ege David S. | See Remarks | M | Common Stock | 11361 | $0.00 | 71,057.0000 | 0 | 19.03% | 0.00% |
| Oct. 30, 2023 | Seres Therapeutics, Inc. | $MCRB | Ege David S. | See Remarks | S | Common Stock | 4066 | $1.35 | 66,991.0000 | 0 | 5.72% | 0.00% |
| April 27, 2023 | Seres Therapeutics, Inc. | $MCRB | Ege David S. | See Remarks | A | Restricted Stock Units | 22721 | $0.00 | 22,721.0000 | 0 | 9999.99% | 0.00% |
| Oct. 27, 2023 | Seres Therapeutics, Inc. | $MCRB | Ege David S. | See Remarks | M | Restricted Stock Units | 11361 | $0.00 | 11,360.0000 | 0 | 50.00% | 0.00% |
| April 27, 2023 | Seres Therapeutics, Inc. | $MCRB | Ege David S. | See Remarks | A | Common stock | 20000 | $0.00 | 66,734.0000 | 0 | 42.80% | 0.00% |
| April 28, 2023 | Seres Therapeutics, Inc. | $MCRB | Ege David S. | See Remarks | S | Common stock | 7038 | $5.19 | 59,696.0000 | 0 | 10.55% | 0.00% |
| Feb. 3, 2023 | Seres Therapeutics, Inc. | $MCRB | Ege David S. | See Remarks | A | Restricted Stock Units | 47500 | $0.00 | 47,500.0000 | 0 | 9999.99% | 0.00% |
| Feb. 3, 2023 | Seres Therapeutics, Inc. | $MCRB | Ege David S. | See Remarks | A | Stock Option (Right to Buy) | 95000 | $0.00 | 95,000.0000 | 0 | 9999.99% | 0.00% |